To determine if the effects of TNFR1 blockade on subcutaneously implanted KPC cells could be extended to the naturally occurring disease, 7- to 8-week-old KPC mice were screened by ultrasound for the appearance of pancreatic tumors. The gene discussed is TNFRSF1A; the disease is pancreatic neoplasm.